Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Oophorectomy reduces ovarian cancer risk for women with BRCA mutations, finasteride lowers prostate cancer risk without raising death risk, and prophylactic mastectomy rates are rising.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Eruca sativa oil, Aloe vera oil, and sodium carbonate may help improve cholesterol and tumor markers in breast cancer treatment.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

A woman developed lupus after taking hydroxyurea for two years.

The rash resolved after stopping ponatinib.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Finasteride helps female-pattern hair loss.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

JAK inhibitors may help improve symptoms in adults with APECED.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

INVERSION Femme supplement helped women lose weight, reduce hair loss, and improve skin and nail health.

Erlotinib can cause persistent excessive hair growth.

Women also use 5α-reductase inhibitors, and their effects differ from men.

Isaria cicadae Miquel rice fermentation extract helps heal wounds and regenerate hair follicles.

Taking oral contraceptives while on isotretinoin may increase the risk of high triglyceride and cholesterol levels.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Letrozole reduces seizures but not brain damage in mice.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

The inhibitor affects androgen metabolism but not ovarian function.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Certain medications can cause serious side effects, so it's important to report them.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.